- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05843266
Early Childhood Attention Battery in Preterm Children
May 2, 2023 updated by: Ricci Daniela, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Study on the Application of the Early Childhood Attention Battery in a Population of Preterms Children
The aims of this project are:
- To explore, using the ECAB, if and in which measure the attentional abilities of young preterm children are different from term peers, whom reference data are already published27.
- To correlate the ECAB results with the "Conner's Teacher, Rating Scale- Revised e Conner's Parent Rating Scale", one of the available diagnostic interview that helps to identify signs of Attention Deficit Hyperactivity Disorder (ADHD) in young children, at the age of 6 years and over.
- To study individual trajectories of attention pattern and development during age.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Daniela Ricci, Medical Doctor
- Phone Number: 3929477842
- Email: d.ricci@iapb.it
Study Locations
-
-
-
Rome, Italy, 00168
- Recruiting
- Fondazione Policlinico Gemelli
-
Contact:
- Daniela Ricci
- Phone Number: +393929477842
- Email: d.ricci@iapb.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Low risk preterm children
Description
Inclusion Criteria:
- gestational age (GA) <34 weeks, intellectual functioning with Intelligence Quotient (IQ>70 verified with Wechsler scales performed within 6 months from the ECAB, age at ECAB assessment between 3 years and 5 years 11 months.
Exclusion Criteria:
- presence of major brain lesions, major motor or behavioral disorders, WPPSI-III subtest receptive vocabulary with a scaled score <8.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
attentional abilities of young preterm children
Time Frame: 3 years
|
The Early Childhood Attention Battery (ECAB) consists of 8 subtest assessing 3 aspects of attention: selective attention, sustained attention, attentional control.
Counting the number of correct answer we get a raw scores (with a different range for each task) that can be translated in a pondered score and in a percentile based on normative data collected on term born children and previously published
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2022
Primary Completion (Anticipated)
June 25, 2023
Study Completion (Anticipated)
June 30, 2023
Study Registration Dates
First Submitted
March 17, 2023
First Submitted That Met QC Criteria
May 2, 2023
First Posted (Estimate)
May 4, 2023
Study Record Updates
Last Update Posted (Estimate)
May 4, 2023
Last Update Submitted That Met QC Criteria
May 2, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4685
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prematurity
-
Stanford UniversityMedtronic - MITGCompletedIntraventricular Hemorrhage of Prematurity | Complications of PrematurityUnited States
-
Universidade Federal do MaranhãoConselho Nacional de Desenvolvimento Científico e TecnológicoUnknown
-
University of WashingtonNational Institute of Neurological Disorders and Stroke (NINDS)CompletedExtreme PrematurityUnited States
-
Guilherme Sant'Anna, MDCompleted
-
University of Kansas Medical CenterCompletedComplication of PrematurityUnited States
-
Zekai Tahir Burak Women's Health Research and Education...UnknownPrematurity of FetusTurkey
-
Mansoura University Children HospitalCompletedPrematurity, Mechanical VentilationEgypt
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; German Federal Ministry of Education and Research; Société des Produits Nestlé (SPN)CompletedPrematurity of FetusGermany
-
Nantes University HospitalActive, not recruitingPrematurity of FetusFrance